Hiperplasia prostática benigna y síntomas del tracto urinario inferior. Revisión de las evidencias actuales

Carrero-López, Víctor Manuel; Cózar-Olmo, J.M.; López, B. Miñana

doi:10.1016/j.acuro.2015.12.008

Cited by 23 publications

(3 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…La HPB se asocia con la edad, siendo más frecuente en los varones mayores de 50 años [4,6], afecta al 50% de la población masculina [3], la probabilidad de desarrollarla es de hasta el 80% y la prevalencia va desde el 10 % a los 30 a 40 años hasta 80-90 % en los > 70 años [3][4][5]. La prevalencia de STUI se incrementa conforme la edad y oscila entre 16.6 % a los 40 años, hasta un aproximado de 40 % a los 60, con una media de 20 a 30 % en los hombres a partir de los 50 [7,8].…”

Section: Hiperplasia Prostática Benigna Versus Cáncer De Próstataunclassified

See 1 more Smart Citation

Propuesta algoritmo de cribado para alteraciones morfológicas de la Próstata. Revisión de la evidencia actual.

Cano

Crow

2018

Rev. Oncol. Ecu.

View full text Add to dashboard Cite

Las alteraciones morfológicas de la próstata, por las que se realiza cribado son la hiperplasiaprostática benigna (HPB) y el cáncer de próstata (CaP). La HPB es el tumor benigno más frecuenteen varones mayores de 50 años, se caracteriza por el aumento del volumen de la glándula y usualmente acompañado de síntomas urinarios. El CaP es la segunda causa de muerte relacionada con cáncer en Estados Unidos y Europa en mayores de 70 años, su incidencia por debajo de los 50 es rara. El cribado o pruebas de detección, tiene como meta el hallar el cáncer antes de la aparición de síntomas, el cribado no se realiza en pacientes por sospechar que tienen cáncer, sino como un método de pesquisa. El objetivo de este artículo, es efectuar una revisión a los referentes teóricos, y proponer un nuevo algoritmo diagnóstico de alteraciones morfológicas de la próstata, basado en la evidencia.

show abstract

Section: Hiperplasia Prostática Benigna Versus Cáncer De Próstataunclassified

“…El UAP puede seguir utilizándose basados los recursos financieros de los pacientes. Además puede resultar útil en pacientes con síntomas urinarios bajos, debido a la detección de la obstrucción vesical, definida por el grosor del músculo detrusor a partir de 2-2.9 mm, los cuales se asocian con HPB [7].…”

Section: Métodos De Cribadounclassified

Propuesta algoritmo de cribado para alteraciones morfológicas de la Próstata. Revisión de la evidencia actual.

Cano

Crow

2018

Rev. Oncol. Ecu.

View full text Add to dashboard Cite

show abstract

“…The symptoms originate from the obstruction of the lower urinary tract and are classified as: obstructive, weak urinary urination, abdominal effort, difficulty in initiating urination, intermittent urination, incomplete bladder evacuation and post-void drip; and irritative, frequency, nocturia, urgency urination, urinary urge incontinence, and dysuria [5]. The high frequency of presentation of these symptoms is correlated with a perception of worsening quality of life, and can lead to deterioration in the patient's work activity and productivity, in addition to leading to stress, depression and social isolation [6].…”

Section: Introductionmentioning

confidence: 99%

Association between Quality of Life and Lower Urinary Tract Symptoms in Patients with Benign Prostatic Hyperplasia in Tijuana, Mexico

LA¹,

MF²,

MA³

et al. 2022

jfammed

View full text Add to dashboard Cite

Background: Benign prostatic hyperplasia (BPH) is one of the main urological pathologies that affects men in adulthood. The high frequency of the symptoms of this pathology is correlated with a perception of worsening of the quality of life, and can lead to deterioration in the activity and work productivity of the patient, leading to stress, depression and social isolation. Objective: To know the association between quality of life and prostate symptoms in patients with benign prostatic hyperplasia in the family medicine unit #27 of Tijuana, Mexico. Methods: Participants answered IPSS questionnaire to determine the severity of lower urinary tract symptoms and quality of life. Descriptive statistics were used, the qualitative variables were expressed in frequencies and percentages, and the quantitative variables in measures of central tendency and dispersion. The assumption of normality was made by the Kolmogorov-Smirnov test. The Chi-squared test was used to analyze differences in categorical variables, and the Odds ratio was used to calculate risk. The information obtained was analyzed in the statistical program SPSS version 25. Results: A total of 356 patients were included in the study. In the evaluation of the severity of prostate symptoms, 59.27% presented mild symptoms (n=211). Regarding quality of life results, 76.69% (n=273) considered as good quality of life, finding an association between both variables (P <0.001). Conclusions: We can conclude that there is an association between the severity of prostate symptoms and quality of life. It is important to constantly evaluate the presence of symptoms, in order to carry out preventive actions to avoid the effect on the quality of life of these patients.

show abstract

A potential therapeutic strategy for prostatic disease by targeting the oral microbiome

Fang

Zhu

et al. 2020

Medicinal Research Reviews

View full text Add to dashboard Cite

Nowadays, human microbiome research is rapidly growing and emerging evidence has witnessed the critical role that oral microbiome plays in the process of human health and disease. Oral microbial dysbiosis has been confirmed as a contributory cause for diseases in multiple body systems, ranging from the oral cavity to the gastrointestinal, endocrine, immune, cardiovascular, and even nervous system. As research progressing, oral microbiome‐based diagnosis and therapy are proposed and applied, which may represent potential drug targets in systemic diseases. Recent studies have uncovered the possible association between periodontal disease and prostatic disease, suggesting new prevention and therapeutic treatment for the disease by targeting periodontal pathogens. Thus, we performed this review to first explore the association between the oral microbiome and prostatic disease, according to current knowledge based on published articles, and then mainly focus on the underlying molecular and cellular mechanisms and the potential prevention and treatment derived from these mechanistic studies.

show abstract

Hiperplasia prostática benigna y síntomas del tracto urinario inferior. Revisión de las evidencias actuales

Cited by 23 publications

References 25 publications

Propuesta algoritmo de cribado para alteraciones morfológicas de la Próstata. Revisión de la evidencia actual.

Propuesta algoritmo de cribado para alteraciones morfológicas de la Próstata. Revisión de la evidencia actual.

Association between Quality of Life and Lower Urinary Tract Symptoms in Patients with Benign Prostatic Hyperplasia in Tijuana, Mexico

A potential therapeutic strategy for prostatic disease by targeting the oral microbiome

Contact Info

Product

Resources

About